Previous 10 | Next 10 |
Image source: The Motley Fool. Meridian Bioscience Inc (NASDAQ: VIVO) Q2 2020 Earnings Call May 9, 2020 , 9:00 p.m. ET Operator Continue reading
Meridian Bioscience, Inc. (VIVO) Q2 2020 Earnings Conference Call May 08, 2020 10:00 AM ET Corporate Participants Charlie Wood - Vice President, Investor Relations Jack Kenny - Chief Executive Officer Bryan Baldasare - Chief Financial Officer Conference Call Participants An...
The following slide deck was published by Meridian Bioscience, Inc. in conjunction with their 2020 Q2 earnings Read more ...
PAR Technology (NYSE: PAR ) +37% on Q1 results . More news on: PAR Technology Corporation, Penn Virginia Corporation, Camping World Holdings, Inc., Stocks on the move, , Read more ...
Meridian Bioscience ( VIVO ) Q2 results : More news on: Meridian Bioscience, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
Meridian Bioscience (NASDAQ: VIVO ): Q2 Non-GAAP EPS of $0.23 beats by $0.15 ; GAAP EPS of $0.22. More news on: Meridian Bioscience, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
CINCINNATI, May 08, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the second quarter ended March 31, 2020. Second Quarter Fiscal 2020 Highlights: Consolidated Net Revenue of $57.3 million, up 14% year-over-year Life Science s...
Meridian Bioscience (NASDAQ: VIVO) was a healthcare sector standout on Wednesday. Since any participation in the fight against the coronavirus is welcome, investors were pleased with the company's announcement that it is supplying reagents for peer diagnostics company QuantuMDx on the latt...
CINCINNATI, May 06, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, is pleased to announce its collaboration with QuantuMDx on its newly launched SARS-CoV-2 assay for laboratory use. ...
CINCINNATI, April 30, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, has completed its previously announced acquisition of Exalenz Bioscience Ltd., the Modiin, Israel based provider of the BreathI...
News, Short Squeeze, Breakout and More Instantly...
Meridian Bioscience Inc. Company Name:
VIVO Stock Symbol:
NASDAQ Market:
Meridian Bioscience Inc. Website:
Net revenue for Q4 2022 was $7.1 million, a 15% increase from prior quarter. Net revenue for 2022 was $25.4 million, a 2% increase compared to 2021. Net losses have decreased by 21.2 million in 2022, a 30% decrease from the prior year. The Company signed a definitive agreemen...
Toronto, Ontario--(Newsfile Corp. - March 24, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) (" VIVO ") is pleased to announce that it has obtained a final court order (the " Final Order ") from the Ontario Superior Court of Justice (Commercial List) approving the previously announced pl...
Toronto, Ontario--(Newsfile Corp. - March 21, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) (" VIVO ") is pleased to announce that, at the special meeting of the shareholders of VIVO (the " Shareholders ") held today (the " Meeting "), the Shareholders approved (i) a special resolutio...